Efficacy of steroid therapy for pacing failure in a patient with chronic myocarditis

Nobuyuki Mitsuya1, Ryoji Kishi, Noriyuki Suzuki

  • 1Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki.

Insights

Steroid therapy stabilized pacing thresholds in a patient with chronic myocarditis by reducing inflammation and fibrosis. However, this treatment did not improve overall cardiac function.

Area of Science:

  • Cardiology
  • Immunology

Background:

  • Chronic myocarditis can lead to progressive cardiac conduction abnormalities, such as increased pacing thresholds.
  • Pacemaker dependency can arise from inflammatory cardiomyopathies, necessitating careful management.

Observation:

  • A 66-year-old male patient experienced a progressive increase in pacemaker pacing threshold over one year due to chronic myocarditis.
  • Biomarkers including serum creatine kinase, cardiac myosin light chains, and pro-collagen III peptide decreased after steroid therapy.

Findings:

  • Steroid therapy successfully decreased and stabilized the patient's pacing threshold, indicating improved electrical conduction.
  • Endocardial biopsy revealed no progression of cardiac fibrosis, suggesting suppression of the inflammatory process.
  • Despite improvements in pacing parameters and reduced fibrosis, cardiac function did not show significant improvement.

Implications:

  • Steroid therapy may be effective in managing pacing threshold issues in chronic myocarditis by mitigating inflammation and fibrosis.
  • The dissociation between improved pacing parameters and unchanged cardiac function highlights the complex pathophysiology of myocarditis.
  • Further research is needed to explore strategies for functional recovery in patients with myocarditis treated with immunosuppressants.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...